BackOrgenesis Overview

Orgenesis Current Assets

Orgenesis's current assets is $2.5M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$2.52M
71.30% YoYΔ $-6.26M vs prior year quarter

Peer trimmed avg / median

Loading

Orgenesis Current Assets History

Loading

Orgenesis vs. peers: Current Assets Comparison

Loading

Orgenesis Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orgenesis (ORGS) FAQ

As of the most recent data (September 2024), ORGS shows a current assets of $2.5M. That compares with $8.8M in the prior-year period — down 71.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORGS's current assets is now $2.5M (was $8.8M) — a 71.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orgenesis is outperforming or lagging.

Tracking ORGS's current assets over time shows whether Orgenesis is scaling, shrinking, or reshaping that part of the business. The current reading is $2.5M That compares with $8.8M in the prior-year period — down 71.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Orgenesis's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $2.5M) with ownership activity and broader fundamentals.

Orgenesis's current assets is $2.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.